IE000L4EH2K5.SG - Overview

IE000L4EH2K5.SG Invesco S&P World Health Care ESG UCITS ETF Acc | IE000L4EH2K5

TER

0.18%

Total Expense Ratio per year

Fund Size

$10503.61B

Assets under management

Holdings

75

Underlying equities

Dividend Yield

N/A

Accumulating

Performance Analysis

Based on selected timeframe (1D)

Top Performers - Upside

ROCHE I RO.SW

+5.15%

ROCHE PS ROP.SW

+5.14%

ARGENX SE ARGX.BR

+5.09%

Top Performers - Downside

SARTORIUS STED BIO DIM.PA

-6.45%

Coloplast B A/S COLO-B.CO

-3.16%

ICON plc ICLR

-2.68%

Top Contributors - Upside

ROCHE PS ROP.SW • Weight: 4.28% • Perf: +5.14%

+0.22% Impact

Eli Lilly and Company LLY • Weight: 17.46% • Perf: +0.86%

+0.15% Impact

AbbVie Inc. ABBV • Weight: 11.51% • Perf: +0.95%

+0.11% Impact

Top Contributors - Downside

Gilead Sciences, Inc. Weight: 4.22% • Perf: -1.18%

-0.05% Impact

Pfizer, Inc. Weight: 2.01% • Perf: -1.88%

-0.04% Impact

Thermo Fisher Scientific Inc Weight: 3.03% • Perf: -0.71%

-0.02% Impact

ETF Profile

Provider Invesco

Region World

Country N/A

Sector Health Care

Strategy Social / Environmental

Theme N/A

Distribution Policy Accumulating

Replication Full replication

Sustainable Yes

Aggregate Fundamentals

Weighted average of underlying holdings

Avg P/E Ratio 29.48

Avg Forward P/E 17.37

Growth Analysis

EPS Growth (LY->CY) +7.03%

Revenue Growth (LY->CY) +19.99%

EPS Growth (CY->NY) +87.00%

Revenue Growth (CY->NY) +7.53%